Blackwood v. Atrium Medical Corporation

CourtDistrict Court, D. New Hampshire
DecidedAugust 12, 2019
Docket1:16-cv-00379
StatusUnknown

This text of Blackwood v. Atrium Medical Corporation (Blackwood v. Atrium Medical Corporation) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Blackwood v. Atrium Medical Corporation, (D.N.H. 2019).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Felicia Blackwood

v. Civil No. 16-cv-379-LM Opinion No. 2019 DNH 128 Atrium Medical Corporation, Maquet Cardiovascular US Sales, LLC, and Getinge AB

In re: Atrium Medical Corp. C-QUR Mesh Products Liability Litigation (MDL No. 2753)

O R D E R Felicia Blackwood brings suit against Atrium Medical Corporation (“Atrium”), a medical device company that manufactured and sold C-QUR Mesh, and two related companies, Maquet Cardiovascular US Sales, LLC (“Maquet”) and Getinge AB (“Getinge”), alleging product liability claims and violation of consumer protection laws. Blackwood’s suit is part of a multi- district litigation (“MDL”) proceeding involving claims that C-QUR Mesh was, among other things, defective and unreasonably dangerous and caused injury when surgically implanted for hernia repair. Her case was selected in the MDL proceeding for the Initial Discovery Pool, making it a bellwether case. Defendants Atrium and Maquet move to dismiss certain of Blackwood’s claims asserted in her second amended complaint on the grounds that they are barred by the statute of limitations and that she has not stated an actionable claim for relief.1 Blackwood objects, arguing that the discovery rule applies to make her claims timely and that she has alleged actionable claims.

1 Getinge has filed a separate motion to dismiss in the main MDL case contending that the court lacks personal jurisdiction over it. That motion remains pending. Getinge does not join in the instant motion. STANDARD OF REVIEW Under Rule 12(b)(6), the court must accept the factual allegations in the complaint as true, construe reasonable inferences in the plaintiff’s favor, and “determine whether the factual allegations in the plaintiff’s complaint set forth a plausible claim upon which relief may be granted.” Foley v. Wells Fargo Bank, N.A., 772 F.3d 63, 71 (1st Cir. 2014) (internal quotation

marks omitted). A claim is facially plausible “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009).

BACKGROUND Blackwood had an open umbilical hernia repair on September 27, 2012, in Beaufort, South Carolina. The surgeon used C-QUR V patch mesh, which defendants manufactured and sold to her physicians, for the repair. On February 27, 2013, Blackwood was treated at the hospital in Beaufort for abdominal

pain, diarrhea, constipation, and reflux. She underwent an upper gastrointestinal endoscopy and a CT scan that showed “tiny recurrent fat-containing periumbilical hernia.” Doc. no. 183 at ¶ 82. Because her symptoms continued, Blackwood had a “revision exploratory laparoscopy” on September 17, 2013, which included removal of the C-QUR V patch mesh. Id. Blackwood alleges that as a result of problems caused by defects in the mesh, as detailed below, she has had chronic infections, peritonitis, abdominal deformity, and nerve damage. She alleges that she cannot exert herself physically without pain. Atrium, which designed, marketed, and sold the C-QUR V Patch mesh that was implanted into Blackwood, is located in New Hampshire. Maquet is located in New Jersey, and Getinge is a Swedish corporation. Blackwood alleges that Maquet and Getinge are responsible for Atrium’s actions and exercised control over Atrium with respect to oversight and compliance with applicable safety standards. Blackwood alleges, among other things, that although Atrium failed to properly research and test the mesh and had been notified that the mesh was causing widespread catastrophic

complications, defendants marketed and sold the C-QUR Mesh V Patch as a safe and effective product. She alleges claims for negligence (Count I); strict liability-design defect (Count II); strict liability-manufacturing defect (Count III); strict liability-failure to warn (Count IV); breach of express warranty (Count V); breach of implied warranties of merchantability and fitness of purpose (Count VI); and violation of consumer protection laws (Count VII). She seeks enhanced damages, based on defendants’ knowledge of the defects in and risks associated with their products and concealing or failing to disclose those defects and risks.

DISCUSSION

Defendants contend that Blackwood’s product liability claims, Counts I through IV, and her claim for violation of consumer protection laws, Count VII, are time-barred under New Hampshire’s statute of limitation, RSA 508:4, I. Defendants also argue that Count VII should be dismissed for the additional reason that the allegations in support of that count are insufficient to state a plausible claim for relief. Blackwood objects, arguing that the discovery rule extends the time for her to file her claims and that she properly pleaded her consumer protection laws claim. I. Statute of Limitations The parties agree that New Hampshire law provides the applicable statute of limitations, RSA 508:4, I.2 See TIG Ins. Co. v. EIFlow Ins. Ltd., No. 14-cv-459-JL, 2015 WL 5714686, at *3 (D.N.H. Sept. 29, 2015) (discussing circumstances under which it is appropriate for this court sitting in diversity to apply New Hampshire’s statute of limitations). “Except as otherwise

provided by law, all personal actions, . . . may be brought only within 3 years of the act or omission complained of.” RSA 508:4, I. An exception to that time limit exists when the injury and its causal relationship to the act or omission were not discovered and could not reasonably have been discovered at the time of the act or omission, the action shall be commenced within 3 years of the time the plaintiff discovers, or in the exercise of reasonable diligence should have discovered, the injury and its causal relationship to the act or omission complained of.

RSA 508:4, I. If the defendant meets the initial burden of showing that the action was not brought within three years of the underlying events, to avoid dismissal, the plaintiff must show that the discovery rule or the fraudulent concealment rule applies to extend the time. Beane v. Dana S. Beane & Co., P.C., 160 N.H. 708, 712 (2010).

2 The court notes that New Hampshire’s Consumer Protection Act exempts from the Act all “[t]ransactions entered into more than 3 years prior to the time the plaintiff knew, or reasonably should have known, of the conduct alleged to be in violation of this chapter.” RSA 358-A:3, IV-a. Courts in this district are split as to whether RSA 358-A:3, IV-a is a statute of limitations or whether RSA 508:4, I provides the relevant limitations period for New Hampshire Consumer Protection Act claims. Compare Laura v. Great Lakes Higher Educ. Guar. Corp., No. 17-CV-373-JL, 2018 WL 671174, at *4 (D.N.H. Feb. 1, 2018) (noting that RSA 358-A:3, IV-a is “a three-year statute of limitations on claims brought under [New Hampshire’s] Consumer Protection Act”) with Lehane v. Wachovia Mortg., No. 12-cv-179-PB, 2013 WL 1637166, at *3 n.5 (D.N.H. Apr. 16, 2013) (“I apply the general three-year limitations period [in RSA 508:4, I] because § 358–A:3(IV–a) is not a statute of limitations.”). Because the court’s holding as to the timeliness of Blackwood’s New Hampshire Consumer Protection Act claim is the same regardless of which statute applies, the court addresses the limitations period in RSA 508:4, I only. Defendants contend that Blackwood’s product liability claims are time-barred because she went to the hospital with abdominal pain on February 27, 2013, after the C-QUR mesh product was implanted, and did not file her action until August 22, 2016, more than three years later.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Rodi v. Southern New England School of Law
389 F.3d 5 (First Circuit, 2004)
Beane v. Dana S. Beane & Co., P.C.
7 A.3d 1284 (Supreme Court of New Hampshire, 2010)
Foley v. Wells Fargo Bank, N.A.
772 F.3d 63 (First Circuit, 2014)
DeGrandis v. Children's Hospital Boston
806 F.3d 13 (First Circuit, 2015)
Bray v. Husted
11 F. Supp. 3d 854 (E.D. Kentucky, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Blackwood v. Atrium Medical Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/blackwood-v-atrium-medical-corporation-nhd-2019.